BDBM489698 US10968163, Compound 3::US10968163, Compound 3-A

SMILES [O-]C(=O)C1C(C(C1c1ccccc1)C(=O)OCc1ccccc1)c1ccccc1

InChI Key InChIKey=MOGDSIWEUDLNRF-UHFFFAOYSA-M

Data  6 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 489698   

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM489698(US10968163, Compound 3-A | US10968163, Compound 3)
Affinity DataKi:  70nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489698(US10968163, Compound 3-A | US10968163, Compound 3)
Affinity DataKi:  90nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489698(US10968163, Compound 3-A | US10968163, Compound 3)
Affinity DataKi:  140nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM489698(US10968163, Compound 3-A | US10968163, Compound 3)
Affinity DataKi:  240nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetFatty acid-binding protein, heart(Human)
The State University of New York

US Patent
LigandPNGBDBM489698(US10968163, Compound 3-A | US10968163, Compound 3)
Affinity DataKi:  420nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetFatty acid-binding protein, heart(Human)
The State University of New York

US Patent
LigandPNGBDBM489698(US10968163, Compound 3-A | US10968163, Compound 3)
Affinity DataKi:  700nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent